| 12410183 |
Sars-cov2 main protease inhibitors |
Stephen E. Ammann, Xinpei Cai, Eda Canales, Weng K. Chang, Henok H. Kinfe +9 more |
2025-09-09 |
|
| 12377100 |
Toll like receptor modulator compounds |
Evangelos Aktoudianakis, Richard L. Mackman, Samuel E. Metobo, Michael R. Mish, Hyung-Jung Pyun +1 more |
2025-08-05 |
|
| 12264173 |
Antiviral compounds |
Byoung-Kwon Chun, Michael O' Neil Hanrahan Clarke, Bindu Goyal, Hon Chung Hui, Petr Jansa +3 more |
2025-04-01 |
|
| 12110294 |
CD73 compounds |
Mark J. Bartlett, Michael O' Neil Hanrahan Clarke, Jennifer L. Cosman, Deeba Ensan, Bindu Goyal +9 more |
2024-10-08 |
$323,137,000 |
| 12091420 |
SARS-COV2 main protease inhibitors |
Stephen E. Ammann, Xinpei Cai, Eda Canales, Weng K. Chang, Henok H. Kinfe +8 more |
2024-09-17 |
$320,643,000 |
| 12030903 |
Antiviral compounds |
Daniel H. Byun, Michael O' Neil Hanrahan Clarke, Bindu Goyal, Petr Jansa, Richard L. Mackman +2 more |
2024-07-09 |
$175,383,000 |
| 11919869 |
CD73 compounds |
Mark J. Bartlett, Michael O' Neil Hanrahan Clarke, Jennifer L. Cosman, Deeba Ensan, Bindu Goyal +6 more |
2024-03-05 |
$494,028,000 |
| 11827609 |
Toll like receptor modulator compounds |
Richard L. Mackman, Michael R. Mish, Jeff Zablocki |
2023-11-28 |
$233,454,000 |
| 11767337 |
Antiviral compounds |
Byoung-Kwon Chun, Michael O' Neil Hanrahan Clarke, Bindu Goyal, Hon Chung Hui, Petr Jansa +3 more |
2023-09-26 |
$541,194,000 |
| 11179397 |
Imidazopyrimidine derivatives |
Michael O' Neil Hanrahan Clarke, Xiaochun Han, Tim Hansen, Yunfeng Eric Hu, Dmitry Koltun +6 more |
2021-11-23 |
$216,502,000 |
| 11124487 |
Toll like receptor modulator compounds |
Richard L. Mackman, Michael R. Mish, Jeff Zablocki |
2021-09-21 |
$207,464,000 |
| 10640499 |
Toll like receptor modulator compounds |
Richard L. Mackman, Michael R. Mish, Jeff Zablocki |
2020-05-05 |
$800,316,000 |
| 10370342 |
Toll like receptor modulator compounds |
Richard L. Mackman, Michael R. Mish, Jeff Zablocki |
2019-08-06 |
$128,404,000 |
| 10285990 |
Toll like receptor modulator compounds |
Evangelos Aktoudianakis, Richard L. Mackman, Samuel E. Metobo, Michael R. Mish, Hyung-Jung Pyun +1 more |
2019-05-14 |
$195,322,000 |
| 10017501 |
Benzimidazole derivatives as bromodomain inhibitors |
Evangelos Aktoudianakis, Britton Kenneth Corkey, Jinfa Du, Kristyna M. Elbel, Robert Jiang +10 more |
2018-07-10 |
$525,460,000 |
| 9670205 |
Toll like receptor modulator compounds |
Evangelos Aktoudianakis, Richard L. Mackman, Samuel E. Metobo, Michael R. Mish, Hyung-Jung Pyun +1 more |
2017-06-06 |
$404,622,000 |
| 9458145 |
Benzimidazole derivatives as bromodomain inhibitors |
Evangelos Aktoudianakis, Britton Kenneth Corkey, Jinfa Du, Kristyna M. Elbel, Robert Jiang +10 more |
2016-10-04 |
$144,218,000 |
| 9255089 |
Benzimidazolone derivatives as bromodomain inhibitors |
Evangelos Aktoudianakis, Britton Kenneth Corkey, Jinfa Du, Kristyna M. Elbel, Robert Jiang +8 more |
2016-02-09 |
$342,012,000 |